American Pharmaceutical Partners Inc. A securities class action lawsuit brought against the company has been dropped. The plaintiffs originally sought compensation for false and misleading information regarding financial statements about Abraxane, a breast cancer treatment medication. The class included investors who purchased American Pharmaceutical Partners' stock from Feb. 19, 2002, to Oct. 6, 2003. (Mar-14-05)
If you have a similar problem and would like to be contacted by a lawyer at no obligation, please fill in our form on the right
to submit your complaint.